WO2006061849A1 - Nouveaux aliments fonctionnels favorables a la sante renforces en herbes medicinales - Google Patents
Nouveaux aliments fonctionnels favorables a la sante renforces en herbes medicinales Download PDFInfo
- Publication number
- WO2006061849A1 WO2006061849A1 PCT/IN2004/000383 IN2004000383W WO2006061849A1 WO 2006061849 A1 WO2006061849 A1 WO 2006061849A1 IN 2004000383 W IN2004000383 W IN 2004000383W WO 2006061849 A1 WO2006061849 A1 WO 2006061849A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- formulation
- herbal
- herbal composition
- plant
- Prior art date
Links
- 235000013376 functional food Nutrition 0.000 title abstract description 8
- 230000036541 health Effects 0.000 title description 5
- 235000008216 herbs Nutrition 0.000 title description 3
- 230000001737 promoting effect Effects 0.000 title description 3
- 239000000203 mixture Substances 0.000 claims abstract description 104
- 241000196324 Embryophyta Species 0.000 claims abstract description 45
- 240000003147 Amaranthus hypochondriacus Species 0.000 claims abstract description 22
- 239000000284 extract Substances 0.000 claims abstract description 22
- 235000011746 Amaranthus hypochondriacus Nutrition 0.000 claims abstract description 21
- 241000472349 Asparagus adscendens Species 0.000 claims abstract description 21
- 240000007228 Mangifera indica Species 0.000 claims abstract description 21
- 240000004482 Withania somnifera Species 0.000 claims abstract description 21
- 235000014826 Mangifera indica Nutrition 0.000 claims abstract description 20
- 235000001978 Withania somnifera Nutrition 0.000 claims abstract description 20
- 230000000694 effects Effects 0.000 claims abstract description 20
- SASUFNRGCZMRFD-JCUIILOWSA-N withanolide D Chemical compound C1C(C)=C(C)C(=O)O[C@H]1[C@](C)(O)[C@@H]1[C@@]2(C)CC[C@@H]3[C@@]4(C)C(=O)C=C[C@H](O)[C@@]54O[C@@H]5C[C@H]3[C@@H]2CC1 SASUFNRGCZMRFD-JCUIILOWSA-N 0.000 claims abstract description 20
- 241000124846 Evolvulus alsinoides Species 0.000 claims abstract description 18
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 12
- 230000002180 anti-stress Effects 0.000 claims abstract description 9
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 8
- 235000015110 jellies Nutrition 0.000 claims abstract description 8
- 244000299461 Theobroma cacao Species 0.000 claims abstract description 7
- 235000019219 chocolate Nutrition 0.000 claims abstract description 7
- 239000006071 cream Substances 0.000 claims abstract description 6
- 239000008274 jelly Substances 0.000 claims abstract description 5
- 238000009472 formulation Methods 0.000 claims description 50
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 230000003389 potentiating effect Effects 0.000 claims description 14
- 235000013399 edible fruits Nutrition 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 12
- 239000012674 herbal formulation Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 102000016938 Catalase Human genes 0.000 claims description 5
- 108010053835 Catalase Proteins 0.000 claims description 5
- 235000015097 nutrients Nutrition 0.000 claims description 5
- 239000000419 plant extract Substances 0.000 claims description 5
- 239000006188 syrup Substances 0.000 claims description 5
- 235000020357 syrup Nutrition 0.000 claims description 5
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 4
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 4
- 235000015872 dietary supplement Nutrition 0.000 claims description 4
- 230000002708 enhancing effect Effects 0.000 claims description 4
- 230000002255 enzymatic effect Effects 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 230000003859 lipid peroxidation Effects 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 3
- 235000014633 carbohydrates Nutrition 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 235000020776 essential amino acid Nutrition 0.000 claims description 3
- 239000003797 essential amino acid Substances 0.000 claims description 3
- 239000006186 oral dosage form Substances 0.000 claims description 3
- 229940123457 Free radical scavenger Drugs 0.000 claims description 2
- 230000000975 bioactive effect Effects 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000005764 inhibitory process Effects 0.000 claims description 2
- 235000004213 low-fat Nutrition 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000002516 radical scavenger Substances 0.000 claims description 2
- 229940032362 superoxide dismutase Drugs 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims 2
- 238000000227 grinding Methods 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 abstract description 4
- 235000006708 antioxidants Nutrition 0.000 abstract description 3
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- 208000025865 Ulcer Diseases 0.000 description 11
- 230000035882 stress Effects 0.000 description 9
- 231100000397 ulcer Toxicity 0.000 description 9
- 206010037660 Pyrexia Diseases 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 description 6
- RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 description 6
- 239000002934 diuretic Substances 0.000 description 5
- 230000001882 diuretic effect Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- AEDDIBAIWPIIBD-ZJKJAXBQSA-N mangiferin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC=2C(=CC(O)=C(O)C=2)C2=O)C2=C1O AEDDIBAIWPIIBD-ZJKJAXBQSA-N 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 230000037326 chronic stress Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000002417 nutraceutical Substances 0.000 description 3
- 235000021436 nutraceutical agent Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 2
- 102000013563 Acid Phosphatase Human genes 0.000 description 2
- 108010051457 Acid Phosphatase Proteins 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- YWQSXCGKJDUYTL-UHFFFAOYSA-N Mangiferin Natural products CC(CCC=C(C)C)C1CC(C)C2C3CCC4C(C)(C)CCCC45CC35CCC12C YWQSXCGKJDUYTL-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 239000003048 aphrodisiac agent Substances 0.000 description 2
- 230000002509 aphrodisiac effect Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 235000014106 fortified food Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 230000002475 laxative effect Effects 0.000 description 2
- 229940043357 mangiferin Drugs 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- -1 tryptophan Chemical class 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- FYYIHVSEGVWNCF-RMDUJBCISA-N (2r)-2-[(1s)-1-[(1s,3r,8s,9s,10r,13s,14s,17r)-1,3-dihydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl]ethyl]-5-(hydroxymethyl)-4-methyl-2,3-dihydropyran-6-one Chemical compound C([C@@H]1[C@H]([C@@H]2[C@]3(CC[C@@H]4[C@@]5(C)[C@@H](O)C[C@H](O)CC5=CC[C@H]4[C@@H]3CC2)C)C)C(C)=C(CO)C(=O)O1 FYYIHVSEGVWNCF-RMDUJBCISA-N 0.000 description 1
- HDPSXKXQSOVYLL-PQSJUMPYSA-N 1,6,7-trihydroxy-3-methoxy-2-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]xanthen-9-one Chemical compound COC1=CC=2OC3=CC(O)=C(O)C=C3C(=O)C=2C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HDPSXKXQSOVYLL-PQSJUMPYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- XGGAWFDOIDZRPI-UHFFFAOYSA-N 4,6-Dihydroxy Natural products C1=C2OCOC2=CC(C2OC(C3C(OC(O)C32)C=2C=C3OCOC3=CC=2)O)=C1 XGGAWFDOIDZRPI-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000219317 Amaranthaceae Species 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 241000208223 Anacardiaceae Species 0.000 description 1
- 241000123643 Asparagaceae Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 229930182476 C-glycoside Natural products 0.000 description 1
- 150000000700 C-glycosides Chemical class 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000207782 Convolvulaceae Species 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241001093152 Mangifera Species 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 244000136948 Ocimum sanctum Species 0.000 description 1
- 235000004072 Ocimum sanctum Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000029132 Paronychia Species 0.000 description 1
- 206010034016 Paronychia Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000016599 Uterine disease Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000012675 alcoholic extract Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000023819 chronic asthma Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013367 dietary fats Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000002554 disease preventive effect Effects 0.000 description 1
- 235000021038 drupes Nutrition 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 206010014801 endophthalmitis Diseases 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000013569 fruit product Nutrition 0.000 description 1
- 239000005467 galactogogue Substances 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 239000010520 ghee Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000010196 hermaphroditism Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- JQXQSODWXYOXRX-UHFFFAOYSA-N homomangiferin Natural products COC1=CC=2OC3=CC(O)=C(O)C=C3C(=O)C=2C(O)=C1OC1OC(CO)C(O)C(O)C1O JQXQSODWXYOXRX-UHFFFAOYSA-N 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- XRSFADLIOJRIOB-UHFFFAOYSA-N indicoside A Natural products OC1C(O)C(C(CO)OC)OC1OCC(O)(C(C)C)CCC(C)C1C(CCC2C3(C(O)C(O)C4CC(O)CCC42C)O)(C)C3C(O)C1 XRSFADLIOJRIOB-UHFFFAOYSA-N 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 231100000863 loss of memory Toxicity 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- DUBCCGAQYVUYEU-ZUGPOPFOSA-N miquelianin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O DUBCCGAQYVUYEU-ZUGPOPFOSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000012254 powdered material Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- FYYIHVSEGVWNCF-UHFFFAOYSA-N pubesenolide Natural products C1CC2C3CC=C4CC(O)CC(O)C4(C)C3CCC2(C)C1C(C)C1CC(C)=C(CO)C(=O)O1 FYYIHVSEGVWNCF-UHFFFAOYSA-N 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- DUBCCGAQYVUYEU-GGTBVAQXSA-N quercetin-3-glucuronide Natural products O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O DUBCCGAQYVUYEU-GGTBVAQXSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003364 shikimic acids Chemical class 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- UCCVFIJDMYRBIT-UHFFFAOYSA-N sominolide Natural products CC(C1CC(=C(CO)C(=O)O1)C)C2CC3OC34C5CCC6C(O)C=CC(=O)C6(C)C5CCC24C UCCVFIJDMYRBIT-UHFFFAOYSA-N 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/10—Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to development of a jam with novel herbal composition(s).
- the present invention provides to a novel herbal composition, ' which promotes the proven pharmacological activities such as anti-oxidant, anti-stress and adaptogenic activities.
- Composition(s) comprises of plant juices or extracts together with the conventional recipients to form a paste/jelly/jam/cake/cream puff/chocolate forms fortified with these plants are added which are used as functional foods.
- nutraceutical is dietary disease preventive food component.
- Food industries have rather high demand for the products that meet the consumer's demand for a healthy life style.
- functional food fortified with the plant ingredients plays an important role. These foods are not intended only to satisfy hunger and provide humans with necessary nutrients but also to prevent mal-nutrition related diseases and increases physical and mental well being of consumers.
- Functional foods are substances that provide health benefits beyond the normal nutritional values and nutrients added, which are not naturally occurring in that food are called as functional fortified food.
- the main objective of the present invention is to provide a synergistic novel health promoting functional foods fortified with herbs having anti-stress and adaptogenic activity. Another important objective is that the product should be cost effective and of socio-economic benefits.
- the present invention provides an herbal formulation useful in stress conditions as an anti-stress agent and adaptogenic activity.
- the herbal formulation comprising of Evo ⁇ vulus alsinoides along with this, Mangifera indica,, Wiihania somnifera, Asparagus recemosus and Amaranthus hypochondriacus are added to provide adaptogenic activity and relief in other symptoms.
- W. somnifera showed 30-40% protection in stress induced gastric ulcers.
- the formulation of the present invention showed highly significant (about 80%) results in stress induced gastric ulcers and therefore the formulation can be used as an adaptogenic and showed antistress activity.
- the plants used in the invention have the following properties as reported.
- Botanical description A large, evergreen tree, 10-45 m tall, with a heavy, dome - shaped crown and a straight, stout bole. Bark thick, dark grey, flaking off when old. Leaves linear oblong or elliptic - lanceolate, 10-30 cm long and 2-9 cm wide, with an aromatic, resinous odour when crushed. Inflorescence a large panicle, containing up to 3000 flowers; flowers tiny, reddish- white or yellowish green with a pungent odour; staminate and hermaphrodite flowers borne in the same panicle.
- Fruit a large drupe, highly variable in form and size; fruit skin thick or thin, leathery, green, yellowish or red, often dotted with numerous glands; flesh (mesocarp) whitish-yellow, yellow or orange, firm, soft or juicy, slightly acidic to sweet, richly aromatic; seed solitary, ovoid-oblique, encased in a hard, compressed, fibrous endocarp (stone).
- Ripe mango fruit is a rich source of vitamins A and C, recommended as a laxative and diuretic and a restorative tonic, and useful for treating heat stroke. It is also thought to be useful for treating haemorrhage of the uterus, lungs and intestine.
- the unripe fruits are used for treating ophthalmia.
- the leaves are chewed to give tone to the gums.
- a c old aqueous extract of the tender leaves is taken internally to relieve diarrhoea in parts of southern orissa.
- the gum resin exuded from the cut bark is used in dressing s for cracked feet and scabies, and is considered anti-syphilitic.
- Botanical Description A perennial herb with a small woody and branched rootstock. Its branches are annual, numerous, more than 30 cm long, often prostrate, slender and wiry with long hairs. Leaves are small, entire, elliptic to oblong, obtuse, apiculate, base acute and densely hairy. Petiole is minute or nearly absent. Bracts are linear and persistent. Flowers mostly solitary in upper axils. Corolla blue rotate and broad funnel shaped, Calyx 4 is lobed, lanceolate and the tip acute. Peduncle is long and axillary. Capsule is globose and 4 valved. Seeds are 4 and glabrous.
- the plant contains an alkaloid-shankhapushpine. Fresh plant contains volatile 11 oil. It also contains a yellow neutral fat, an organic acid and saline substances. Three alkaloids- evolvine, betaine, and an unidentified compound have been isolated.
- Botanical description An erect, evergreen, grayish tomentose shrub 0.3- 2 m tall, with fairly long, stout, fleshy, whitish-brown roots.Leaves simple, alternate or subopposite, broadly ovate, glabrous, 5-12 cm long and 2.5 - 7 cm wide, apex subacute, base un equal, marginsentire, finely stellate-pubescent beneath; main nerves about 6 pairs; petioles 0.3- 1.7 cm long.
- Phytochemistry Two new withnolides- 5- dehydroxy withnolide R and with a somniferin A isolated and their structure established (Phytochemistry 1991).
- the roots are considered alternative, germicidal, aphrodisiac and diuretic; they are used in Ayurveda to treat ulcers, fever,dyspnoea, cough, consumption, dropsy, rheumatism, toxicosis and memory loss.
- the powdered roots mixed with equal parts of honey and ghee is thought to be beneficial for impotence or seminal debility.
- the roots as well as the bruised leaves are also used externally to treat ulcers, painful swellings and scabies.
- the total alkaloids present in the roots produce relaxant and anti spasmodic effects.
- the fruits and seeds are diuretic.
- the leaves are considered anthelmintic and bitter, and their infusion is given to relieve fever.
- Asparagus racemosus Family Asparagaceae
- Botanical description A tall climbing, much-branched, spiny shrub with annual woody, white - grey or brown stems armed with strong, straight or recurved spines 0.5 - 1.3 cm long; rootstock short, tuberous, bearing numerous fusiform, succulent tuberous roots 30 - 100 cm long and 1-2 cm thick. Flowers white, fragrant, small, crowded in simple and branched racemes 5 - 15 cm long. Fruits globose, red when ripe, 3-lobed, 0.4 - 0.6 cm in diameter.
- A. hypochondriacus is a beautiful crop with red or green leaves. The plant is monoecious. An erect, branched, annual or perennial herb, varying in colour from green to purple, 30-60 cm tall with hard, strainght, paired axillary spines, Leaves long — petioled, oblong, ovate-elliptic or lanceolate, acute or obtuse, base cuneate, generally 1-6 cm long and 0.5-2.6 cm wide. Flowers minute, grayish-green, borne in dense axillary clusters or terminal spikes; bracts and bracteoles narrowly ovate-lanceolate.
- the grain contains proteins, and is high in lysine, an essential amino acid in which cereal crops are low. Sulphur containing amino acids such as tryptophan, found to be deficient in pulses are present in amaranth seeds. The seeds are also rich in calcium, iron and the b complex vitamins (Subramaniam and srinivasan 1952, Smith et al 1959). Pharmacology:
- the plant is considered diuretic, emollient sudoritic and febrifuge, and is recommended for treating eruptive fevers, as a galactagogue and as a remedy for colic.
- a decoction of the plant is considered useful for improving digestion.
- the leaves are applied as a poultice to relieve bruises, abscesses, burns, wounds and inflammations; their infusion is used as a diuretic.
- the root is used to treat menorrhagia, gonorrhoea, eczema and inflammatory swelling.
- the powdered root is used as a cure for paronychia.
- the roots and leaves are boiled and given to children as a laxative.
- the present invention provides a novel aqntistress herbal synergistic formulation useful for the treatment of acute adaptogenic and antioxidant said formulation comprising:
- aqueous alcoholic extracts of the plants comprising Mangifera indica 65-75 wt. %, Withania somnifera 3.5-5wt. %, Asparagus recemosus 3.5-5wt. %, and Amaranthus hypochondriacus 10-20wt. %, Evolvulus alsinoides 0.2-0.6wt % in an oral dosage form selected from a group consisting of a jam/jellies/chocolates etc.
- the novelty of the present investigation is (1) herbal formulation for the treatment of anti-stress (2) the herbal formulation for the treatment of adaptogenic activities.
- composition(s) wherein the plant selected from powdered plants or lyophilized juice/extracts of plants Mangifera indica, Evolvulus alsinoides, Withania somnifera, Asparagus recemosus and Amaranthus hypochondriacus.
- herbal formulation(s) used in the fields of foods and pharmaceuticals as a nutrient comprises of plant juice or extracts together with the conventional recipients.
- a composition(s) wherein the plants are selected from Mangifera indica fruit.
- composition(s) wherein the powder of obtained from Withania somnifera leaves or roots.
- composition(s) wherein the powder of obtained from Asparagus recemosus tubers.
- herbal composition(s) as claimed in claim 1 wherein the said composition is used as a nutrient supplement and acts as a free radical scavenger.
- herbal composition(s) as claimed in claim 1 wherein said composition forms a paste/jelly/jam/cake/cream puff/chocolate.
- herbal composition(s) as claimed in claim 1 wherein the plant extracts are obtained from plant parts selected from leaf, seeds, rhizome, tubers and aerial parts.
- a method of preparing a herbal composition(s) as claimed in claim 1 comprising: a. obtaining the individual part of medicinal plants from a group comprising leaves, fruits, seeds, root, rhizome, tubers and aerial parts of equal proposition. b. fresh or shade dried plant materials were used, c. crushed/Powdered the plant material to Juice/coarse powder, d. extracting the powdered dried plant material with (40-50% aqueous ethanol) at 25 - 35 0 C, e. preparation of syrup by heating 40-70% w/v sugar in water, f.
- step (e) mixing of plant extract or juice obtained in step (e) like Mangifera indica, Evolvulus alsinoides, Withania somnifera, Asparagus recemosus Amaranthus hypochondriacus in syrup. g. concentrating the composition at high temperature (80-120 0 C) to form a paste/jelly/jam/cake/cream puff/chocolate.
- herbal composition(s) as claimed in claim 1 wherein the formulation showed as a potent antioxidant activity.
- herbal composition(s) as claimed in claim 1 wherein the formulation showed as a potent adaptogenic activity.
- herbal composition(s) as claimed in claim 1 wherein the formulation showed as a potent antistress activity.
- herbal composition(s) as claimed in claim 1 wherein the formulation showed as a potent nonenzymic antioxidant activity.
- herbal composition(s) as claimed in claim 1 wherein the formulation showed an enhanced protein content (0.03-0.06 g/ 1Og).
- herbal composition(s) as claimed in claim 1 wherein the formulation showed an enhanced total carbohydrate and low fat content (0.01 g/ 1Og).
- herbal formulation(s) as claimed in claim 1 wherein the extracts on the basis of one or more bioactive components and are combined in one convenient but tasty formula of fruits in the form of jam or jellies.
- herbal formulation(s) as claimed in claim 1 wherein the formulation helpful in defending the body against the effects of stressful environment and provide vitality and energy.
- the first step in the preparation of these formulations involves a process for making, the plant material suitable for formulating into a solid/semi solid form.
- the specified portion of the plant is collected and dried under shade at room temperature (25 -35 0 C) for 72 hours or until the material gets dried.
- the material is then powdered into a fine powdered.
- a specified amount of the powdered material is then extracted exhaustively with 50 % aqueous alcohol at room temperature (25-35 0 C). Extraction was carried out in a closed container immersing specified amount of the plant material in specified solvent (1 : 8 or 1 : 15 ratio) for 4-7 days. At the end of this stage, solvent is decanted and filtered if necessary to make it free from plant debris.
- Mangifera indica, Evolvulus alsinoides, Withania somnifera, Asparagus recemosus and Amaranthus hypochondriacus were collected and dried in shade.
- the dried material (IKg) is then powdered and extracted with 50 % aqueous alcohol (3 L) for 5 days. At the end of this, the solvent is decanted and filtered if necessary to remove the plant debris.
- the extract is then concentrated under vacuum at less than 50 0 C. Then the extract is lyophilised to obtain the extract in powder form.
- the blood was collected and serum was separated and enzyme like alkaline phosphatase, acid phosphatase, glutamic pyruvic transaminase, lipid peroxidation, superoxide dismutase and catalase are estimated by span diagnostic kit method.
- the formulation Fl- contains the extracts of Mangifera indica (65wt.%), Evolvulus alsinoides (0.4wt.%), Withania somnifera (3wt. %), Asparagus recemosus (4wt.%) and Amaranthus hypochondriacus (14wt. %).
- the formulation F2- contains the extracts of Mangifera indica (65wt.%), Evolvulus alsinoides (0.5wt.%), Withania somnifera (6wt%), Asparagus recemosus (6wt%) and Amaranthus hypochondriacus (15wt%).
- the Formulation F2 acts as an antiulcer agent in stress as indicated in reduction of ulcer index from 100 % to 40 %, number of ulcers from 19.5 to 8.2 and also decrease in severity of ulcers from 32.8 to 12.5.
- Formulation F2 is more significant than Fl formulation.
- the formulation Fl- contains the extracts of Mangifera indica (65wt.%), Evolvulus alsinoides (0.4wt.%), Withania somnifera (3wt. %), Asparagus recemosus (4wt.%) and Amaranthus hypochondriacus (14wt. %).
- the formulation F2- contains the extracts of Mangifera indica (65wt.%), Evolvulus alsinoides (0.5wt.%), Withania somnifera (6wt%), Asparagus recemosus (6wt%) and Amaranthus hypochondriacus (15wt%).
- Adrenal gland weight was increased in chronic stress with the formulation Fl and F2.
- the lipid peroxidation was significantly increased in vehicle + stress group compared to the vehicle group, when we treated with the developed formulations there is a significant decrease in the increased levels and attained to near to normal values.
- the antioxidant enzyme catalase was concomitantly increased from 19.5 to 29.3 and this showed a positive effect compared to the vehicle plus stress group.
- the formulation Fl- contains the extracts of Mangifera indica (65wt.%), Evolvulus alsinoides (0.4wt.%), Withania somnifera (3wt. %), Asparagus recemosus (4wt.%) and Amaranthus hypochondriacus (14wt. %).
- the formulation F2- contains the extracts of Mangifera indica (65wt.%), Evolvulus alsinoides (0.5wt.%), Withania somnifera (6wt%), Asparagus recemosus (6wt%) and Amaranthus hypochondriacus (15wt%). There is no change in the levels of the enzymes viz. alkaline phosphatase, acid phosphatase and glutamic pyruvic transaminase. Quality control of jam
- Hydroxymethylfurfural is a recognised indicator of quality deterioration, as a result of excessive heating or storage in a wide range of foods containing carbohydrates. Its content is practically zero in fresh, untreated fruit juice and HMF formation is judged to be the most useful method for assessing the effectiveness of heat treatment in destroying spoilage organisms in jams and fruit products.
- HMF content immediately after preparation 1.34 mg HMF/ lOOg of Jam and after 1 year, it is 1.64 mg HMF/ 100 g Jam at room temperature.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2004/000383 WO2006061849A1 (fr) | 2004-12-10 | 2004-12-10 | Nouveaux aliments fonctionnels favorables a la sante renforces en herbes medicinales |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2004/000383 WO2006061849A1 (fr) | 2004-12-10 | 2004-12-10 | Nouveaux aliments fonctionnels favorables a la sante renforces en herbes medicinales |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006061849A1 true WO2006061849A1 (fr) | 2006-06-15 |
WO2006061849B1 WO2006061849B1 (fr) | 2006-10-12 |
Family
ID=34960107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2004/000383 WO2006061849A1 (fr) | 2004-12-10 | 2004-12-10 | Nouveaux aliments fonctionnels favorables a la sante renforces en herbes medicinales |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006061849A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3364990A4 (fr) * | 2015-10-22 | 2019-09-18 | Benny Antony | Procédé pour augmenter la bioactivité d'extraits d'ashwaganda |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010055625A1 (en) * | 2000-03-28 | 2001-12-27 | Katiyar Chandra Kant | Herbal composition and method of manufacturing such composition for the management of gynecological disorders |
WO2003017784A1 (fr) * | 2001-08-30 | 2003-03-06 | Council Of Scientific And Industrial Research | Composition nutraceutique a base d'herbes destinee aux femmes/femmes enceintes et son procede de preparation |
JP2003160503A (ja) * | 2001-11-21 | 2003-06-03 | Pola Chem Ind Inc | アサガオカラクサ属植物のエキスからなる血管内皮増殖因子産生促進剤 |
US20030185913A1 (en) * | 2002-03-26 | 2003-10-02 | Palpu Pushpangadan | Herbal health protective and promotive nutraceutical formulation for diabetics and process for preparing the same |
WO2003079812A1 (fr) * | 2002-03-25 | 2003-10-02 | Council Of Scientific And Industrial Research | Aliments fonctionnels d'origine vegetale et procede de preparation correspondant |
US20040121029A1 (en) * | 2002-12-19 | 2004-06-24 | Council Of Scientific & Industrial Research | Antiulcer herbal composition(s) |
WO2004056382A1 (fr) * | 2002-12-20 | 2004-07-08 | Council Of Scientific And Industrial Research | Boisson sans alcool a base d'herbes ayurvediques |
-
2004
- 2004-12-10 WO PCT/IN2004/000383 patent/WO2006061849A1/fr active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010055625A1 (en) * | 2000-03-28 | 2001-12-27 | Katiyar Chandra Kant | Herbal composition and method of manufacturing such composition for the management of gynecological disorders |
WO2003017784A1 (fr) * | 2001-08-30 | 2003-03-06 | Council Of Scientific And Industrial Research | Composition nutraceutique a base d'herbes destinee aux femmes/femmes enceintes et son procede de preparation |
JP2003160503A (ja) * | 2001-11-21 | 2003-06-03 | Pola Chem Ind Inc | アサガオカラクサ属植物のエキスからなる血管内皮増殖因子産生促進剤 |
WO2003079812A1 (fr) * | 2002-03-25 | 2003-10-02 | Council Of Scientific And Industrial Research | Aliments fonctionnels d'origine vegetale et procede de preparation correspondant |
US20030185913A1 (en) * | 2002-03-26 | 2003-10-02 | Palpu Pushpangadan | Herbal health protective and promotive nutraceutical formulation for diabetics and process for preparing the same |
US20040121029A1 (en) * | 2002-12-19 | 2004-06-24 | Council Of Scientific & Industrial Research | Antiulcer herbal composition(s) |
WO2004056382A1 (fr) * | 2002-12-20 | 2004-07-08 | Council Of Scientific And Industrial Research | Boisson sans alcool a base d'herbes ayurvediques |
Non-Patent Citations (1)
Title |
---|
PATENT ABSTRACTS OF JAPAN vol. 2003, no. 10 8 October 2003 (2003-10-08) * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3364990A4 (fr) * | 2015-10-22 | 2019-09-18 | Benny Antony | Procédé pour augmenter la bioactivité d'extraits d'ashwaganda |
Also Published As
Publication number | Publication date |
---|---|
WO2006061849B1 (fr) | 2006-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Preedy et al. | Nuts and seeds in health and disease prevention | |
Aborisade et al. | Phytochemical and proximate analysis of some medicinal leaves | |
KR100372561B1 (ko) | 천연 생약제 추출물을 포함하는 숙취해소용 조성물 및이를 유효성분으로 함유하는 건강보조식품 | |
JP6929954B2 (ja) | モリンガ葉抽出物及び杜仲抽出複合物の抗菌、抗酸化、抗炎症、歯槽骨消失の抑制及び再生による歯肉炎及び歯周炎の改善方法 | |
Besong et al. | Medicinal and economic value of Dialium guineense | |
Ahmad et al. | Medicinal potential of jamun (Syzygium cumini Linn): A review | |
KR20180137174A (ko) | 발모 촉진, 탈모 완화 및 개선용 건강보조식품 | |
Parra et al. | An overview on various aspects of plant Berberis Lycium Royale | |
Jikah et al. | Moringa oleifera: a valuable insight into recent advances in medicinal uses and pharmacological activities | |
Tolekova et al. | Antioxidant, pharmacological, medical properties and chemical content of Rosa L. extracts | |
KR100552398B1 (ko) | 작두콩 추출물을 포함하는 숙취해소용 음료조성물 | |
US7399491B2 (en) | Health promoting functional foods fortified with herbs | |
Rehman et al. | Commercial importance, medicinal value and therapeutic potentials of chaff flower (achyranthes aspera)–a review | |
KR102564887B1 (ko) | 호흡기질환 예방 및 개선용 조성물 | |
JP2002193826A (ja) | 強壮・強精組成物 | |
KR102092509B1 (ko) | 치매 예방 및 개선용 식품 조성물 | |
Singh et al. | Phytochemistry and medicinal uses of moringa oleifera: an overview | |
KR101829810B1 (ko) | 청보리잎과 한약재 추출물을 포함하는 발효 조성물 및 이의 제조 방법 | |
Yadav et al. | Trigonella foenum‑graecum: A herbal plant review | |
Ashok et al. | Nutraceutical values of minor fruits on immunity development to combat diseases | |
De et al. | Nutrient rich foods in human diet as immunity boosters | |
Roy et al. | Herbs Used In Peptic Ulcer: A Review. | |
Lim | Opuntia ficus-indica | |
KR101248378B1 (ko) | 관절염 치료 및 예방용 약학조성물 | |
US7172772B2 (en) | Herbal composition for gastrointestinal disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 04806766 Country of ref document: EP Kind code of ref document: A1 |